Technological advancements in total knee replacement are significantly driving market growth by enhancing surgical precision, improving patient outcomes, and increasing patient satisfaction.
Robotic systems, such as the VELYS Robotic-Assisted Solution, allow for personalized surgical planning and execution. These systems create 3D models of the patient’s knee, enabling surgeons to tailor the procedure to individual anatomy and improve implant positioning accuracy. This technology is associated with less tissue disruption and faster recovery times compared to traditional methods.
Additionally, development of smart implants, for instance, the Persona IQ implant that features integrated sensors that monitor patient activity, such as range of motion and walking speed. This data is transmitted to healthcare providers, allowing for real-time monitoring of recovery and personalized rehabilitation plans. This innovation enhances patient engagement and helps ensure optimal recovery outcomes.
Moreover, the Patient-Specific Instrumentation (PSI) technology involves creating customized surgical instruments based on preoperative imaging. PSI aims to improve the accuracy of implant placement and alignment, which can lead to better functional outcomes and reduced postoperative complications. These advancements not only improve surgical outcomes but also cater to the increasing demand for knee replacements.
Authors:
Mariam Faizullabhoy , Gauri Wani
Frequently Asked Questions (FAQ) :
The global total knee replacement industry was valued at USD 9.4 billion in 2023 and is expected to grow at a 5.1% CAGR from 2024 to 2032, driven by the rising prevalence of arthritis and osteoporosis.
The primary knee replacement systems segment generated USD 7.7 billion in 2023, as these systems are used in initial surgeries, which are more common due to the increasing prevalence of osteoarthritis.
North America total knee replacement industry recorded USD 5.1 billion in 2023 and is anticipated to grow at a 3.8% CAGR between 2024 and 2032, driven by high osteoarthritis prevalence and lifestyle factors like obesity.
Key players in the industry include Amplitude Ortho (Amplitude Surgical), B Braun, Corin Group, Depuy Synthes (Johnson & Johnson), Enovis, Exactech, ODEV, Medacta International, and Allegra Orthopaedics.